Prodia is shifting in a meaningful way towards esoteric testing, which commands significantly higher revenues plus it is building out its genomic testing, which yields higher returns.
What is covered in the Full Insight:
Company Overview
IT Development and Prodia Digital
Financial Performance 1Q2024
Testing Services
Future Projections and Corporate Developments
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.